The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...

You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...

Ogun State officials issue a stark warning to youths about the 'bluetoothing' drug trend, a deadly practice of sharing blood ...

Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...